Article
Using Virtual Patients to Predict Perceptual Outcomes for Optogenetic Sight Recovery Technologies
2026-04-13
Abstract excerpt
Optogenetics is emerging as a powerful approach for partial vision restoration, with at least three ongoing clinical trials in humans testing novel light-sensitive proteins (opsins) in patients with inherited retinal degenerative disorders. These therapies aim to restore light responsiveness by introducing opsins into surviving retinal cells, such as bipolar or ganglion cells, enabling them to generate neural acti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a9f50688-1b75-5bac-9daf-676c1791906d
- DOI
- 10.64898/2026.04.09.716230
